Influenza A/B & COVID-19 RT-PCR

This test, an RT-PCR assay, directly screens for the COVID-19 & Influenza A/B viruses in a patient’s RNA genetic sequence.

It offers the option to test for COVID-19 or a combination of COVID-19 and Influenza A/B. Your testing preference can be made upon activation of the kit.

By scaling molecular testing to test vast groups in a population, doctors can identify and initiate the appropriate therapeutic treatment early. Patients can immediately self-quarantine to minimize the spread of viral infections.

This test includes comprehensive advantages that ensure quality and accuracy including:

• Simultaneous detection and differentiation between Influenza A/B and SARS-CoV-2 (COVID-19)
• RT-PCR is a nasopharyngeal swab, oropharyngeal swab, or saliva test
• This test requires high complexity laboratory instrumentation and must be ordered by a healthcare provider
• Molecular testing is considered the gold standard for testing & diagnosing active viral infections
• Medisure Lab’s molecular tests contains an internal positive control that can verify if the sample taken was sufficient
• Our multiplexed system streamlines testing to provide high throughput and expedited turn-around-time

Point of Care COVID-19 Antigen

Antigen tests detect proteins from the virus SARS-CoV-2.

This test includes comprehensive advantages that ensure quality and accuracy including:

• Quick and easy to use with results available in 20 minutes
• Does not require laboratory instrumentation
• This test can only be administered by a high complexity laboratory personnel
• This tests for active SARS-CoV-2 antigen infection by nasopharyngeal or nasal swab